Treatment.com AI Inc. to Rebrand as Rocket Doctor AI Inc., Aligning Business with Evolving Product Portfolio and Market Strategy

Core Viewpoint - Treatment.com AI Inc. is rebranding as Rocket Doctor AI Inc. to reflect its strategic evolution and commitment to advancing AI-driven healthcare solutions [1][6] Company Overview - The rebranding includes a change in the trading symbol from "TRUE" to "AIDR" on the Canadian Securities Exchange, effective August 21, 2025 [2] - The new name integrates the proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc., a digital health platform that connects physicians with patients across North America [3][5] - The acquisition of Rocket Doctor Inc. in April 2025 enhances Treatment's technology stack, positioning the company to deliver scalable, AI-enhanced healthcare solutions [5][7] Strategic Focus - The new stock symbol AIDR aims to better represent the company's focus on AI-driven administrative, diagnostic, clinical decision support, and referral solutions [4] - The integration of GLM and Rocket Doctor's platform aims to improve healthcare access for rural, remote, and underserved communities in North America [7][9] - The company emphasizes its commitment to delivering practical, clinically validated, and scalable AI solutions while keeping shareholders informed of progress [6] Leadership Insights - Dr. Essam Hamza, CEO, expressed excitement about the rebranding as a natural step in uniting technology and service offerings under a stronger identity [6] - Dr. William Cherniak, CEO of Rocket Doctor Inc., highlighted the focus on improving physicians' practice and increasing access to care for patients [6]